OM
AFIB

Opaleye Management’s Acutus Medical Inc AFIB Stock Holding History

Opaleye Management’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-590,000
Closed -$5.22M – 49
2021
Q3 		$5.22M Sell
590,000
-9,990
-2% -$131K 0.97% 29
2021
Q2 		$10.2M Sell
599,990
-15,000
-2% -$219K 1.69% 18
2021
Q1 		$8.22M Sell
614,990
-135,000
-18% -$3.04M 1.21% 24
2020
Q4 		$21.6M Hold
749,990
– – 2.82% 9
2020
Q3 		$22.4M Buy
+749,990
New +$22.8M 4.37% 5

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Opaleye Management's AFIB Position: Q4 2021 in Review

Opaleye Management sold out of Acutus Medical Inc (AFIB) in Q4 2021, closing a stake of 590,000 shares — an estimated $5.22M sold.

Opaleye Management first reported a position in AFIB in Q3 2020 and held it in 5 quarters. The position peaked at $22.4M in Q3 2020. 71 funds tracked by Wall St. Rank hold AFIB as of Q4 2021.

  • Opaleye Management reported no remaining Acutus Medical Inc position as of Q4 2021 after selling out during the quarter.
  • Opaleye Management sold 590,000 Acutus Medical Inc shares in Q4 2021, an estimated $5.22M.
  • Opaleye Management first reported a position in Acutus Medical Inc in Q3 2020 and held it in 5 quarters.
  • Opaleye Management's Acutus Medical Inc position peaked at $22.4M in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2021.

Based on Opaleye Management's 13F filing for Q4 2021, filed 14 Feb 2022.